Long-Term Efficacy of Rasagiline in Early Parkinson's Disease
β Scribed by Lew, Mark F.; Hauser, Robert A.; Hurtig, Howard I.; Ondo, William G.; Wojcieszek, Joanne; Goren, Tamar; Fitzer-Attas, Cheryl J.
- Book ID
- 125547854
- Publisher
- Informa plc
- Year
- 2010
- Tongue
- English
- Weight
- 267 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0020-7454
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The purpose of this study to compare the longβterm clinical outcome of early versus delayed rasagiline treatment in early Parkinson's disease (PD). Subjects (N = 404) were randomly assigned to initial treatment with rasagiline (earlyβstart group) or placebo for 6 months followed by rasa
## Abstract Several randomized placeboβcontrolled trials have consistently shown antidyskinetic effects of amantadine in levodopa treated patients with advanced Parkinson's disease (PD). However, all of these were of short duration and there have been claims that the effect of amantadine on levodop